Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$801.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 23 most recent Form 4 transactions.
| Jun 5 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 40,000 | — | — | +4.5% | Open the original filing on SEC.gov |
| Jun 3 | PACB | Pacific Biosciences Of… | AGRANT◆ | 74,497 | — | — | — | Open the original filing on SEC.gov |
| May 22 | RXRX | Recursion Pharmaceuticals,… | CCONV◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| May 22 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 40,000 | $3.08 | $123.2K | -4.3% | Open the original filing on SEC.gov |
| May 22 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 40,000 | — | — | +4.5% | Open the original filing on SEC.gov |
| May 15 | RXRX | Recursion Pharmaceuticals,… | FTAX | 22,821 | $3.04 | $69.4K | -2.5% | Open the original filing on SEC.gov |
| May 7 | RXRX | Recursion Pharmaceuticals,… | CCONV◷◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |
| May 7 | RXRX | Recursion Pharmaceuticals,… | GGIFT◷ | 20,000 | — | — | -2.2% | Open the original filing on SEC.gov |
| May 7 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 40,000 | $3.37 | $134.8K | -4.1% | Open the original filing on SEC.gov |
| May 7 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 60,000 | — | — | +6.6% | Open the original filing on SEC.gov |
| Apr 22 | RXRX | Recursion Pharmaceuticals,… | CCONV◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 22 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 40,000 | $3.61 | $144.4K | -4.2% | Open the original filing on SEC.gov |
| Apr 22 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 40,000 | — | — | +4.4% | Open the original filing on SEC.gov |
| Apr 8 | PACB | Pacific Biosciences Of… | AGRANT◆ | 77,842 | — | — | — | Open the original filing on SEC.gov |
| Apr 8 | PACB | Pacific Biosciences Of… | AGRANT | 57,473 | — | — | +106.6% | Open the original filing on SEC.gov |
| Apr 7 | RXRX | Recursion Pharmaceuticals,… | CCONV◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 7 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 40,000 | $3.10 | $124K | -4.2% | Open the original filing on SEC.gov |
| Apr 7 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 40,000 | — | — | +4.4% | Open the original filing on SEC.gov |
| Mar 23 | RXRX | Recursion Pharmaceuticals,… | CCONV◷◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 23 | RXRX | Recursion Pharmaceuticals,… | SSELL◷ | 40,000 | $3.25 | $130K | -4.2% | Open the original filing on SEC.gov |
| Mar 23 | RXRX | Recursion Pharmaceuticals,… | CCONV◷ | 40,000 | — | — | +4.4% | Open the original filing on SEC.gov |